InMode Ltd (INMD)
18.01
-0.99
(-5.21%)
USD |
NASDAQ |
Nov 15, 16:00
18.01
0.00 (0.00%)
After-Hours: 04:41
InMode Revenue (Quarterly): 130.23M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 130.23M |
June 30, 2024 | 86.45M |
March 31, 2024 | 80.28M |
December 31, 2023 | 126.78M |
September 30, 2023 | 123.11M |
June 30, 2023 | 136.08M |
March 31, 2023 | 106.07M |
December 31, 2022 | 133.57M |
September 30, 2022 | 121.23M |
June 30, 2022 | 113.55M |
March 31, 2022 | 85.92M |
December 31, 2021 | 110.54M |
September 30, 2021 | 94.18M |
June 30, 2021 | 87.32M |
Date | Value |
---|---|
March 31, 2021 | 65.52M |
December 31, 2020 | 75.19M |
September 30, 2020 | 59.71M |
June 30, 2020 | 30.76M |
March 31, 2020 | 40.44M |
December 31, 2019 | 47.00M |
September 30, 2019 | 40.01M |
June 30, 2019 | 38.80M |
March 31, 2019 | 30.55M |
December 31, 2018 | 28.78M |
September 30, 2018 | 25.42M |
June 30, 2018 | 25.05M |
March 31, 2018 | 20.91M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
30.76M
Minimum
Jun 2020
136.08M
Maximum
Jun 2023
92.70M
Average
90.75M
Median
Revenue (Quarterly) Benchmarks
Compugen Ltd | 17.13M |
Pluri Inc | 0.096M |
BioLine Rx Ltd | 5.393M |
Can Fite Biofarma Ltd | 0.155M |
BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 50.99M |
Total Expenses (Quarterly) | 81.97M |
EPS Diluted (Quarterly) | 0.65 |
Enterprise Value | 688.36M |
Gross Profit Margin (Quarterly) | 81.53% |
Profit Margin (Quarterly) | 39.15% |
Earnings Yield | 10.27% |
Operating Earnings Yield | 8.98% |
Normalized Earnings Yield | 10.27 |